AC Immune (ACIU)
(Delayed Data from NSDQ)
$3.12 USD
+0.06 (1.96%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $3.14 +0.02 (0.64%) 5:22 PM ET
3-Hold of 5 3
D Value A Growth F Momentum D VGM
Earnings News For ACIU
-
AC Immune (ACIU) Reports Q2 Loss, Lags Revenue Estimates
-
AC Immune: Q2 Earnings Snapshot
-
AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
-
AC Immune: Q1 Earnings Snapshot
-
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
-
AC Immune: Q3 Earnings Snapshot
-
AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
-
AC Immune (ACIU) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
AC Immune (ACIU) Reports Q2 Loss, Misses Revenue Estimates
-
AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
-
AC Immune: Q1 Earnings Snapshot
-
AC Immune Reports First Quarter 2023 Financial Results and Provides a Corporate Update
-
AC Immune (ACIU) Reports Q3 Loss, Tops Revenue Estimates
-
AC Immune: Q3 Earnings Snapshot
-
AC Immune Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
-
AC Immune (ACIU) Reports Q2 Loss, Lags Revenue Estimates
-
AC Immune: Q2 Earnings Snapshot
-
AC Immune Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
AC Immune (ACIU) Reports Q3 Loss, Misses Revenue Estimates
-
Earnings Preview: AC Immune (ACIU) Q3 Earnings Expected to Decline
-
AC Immune (ACIU) Reports Q2 Loss, Lags Revenue Estimates
-
Earnings Preview: AC Immune (ACIU) Q2 Earnings Expected to Decline
-
AC Immune (ACIU) Reports Q1 Loss, Misses Revenue Estimates
-
AC Immune (ACIU) Reports Q3 Loss, Tops Revenue Estimates
-
Earnings Preview: AC Immune (ACIU) Q3 Earnings Expected to Decline